Zenon Rayter is Consultant Surgeon at Bristol Royal Infirmary and Honorary Senior Lecturer at the University of Bristol. He is Director of the Bristol Breast Unit, Chairman of the Breast Site Specialist Group of Avon, Somerset and Wiltshire Cancer Services, and Vice President of the Surgical Section of the Royal Society of Medicine. Janine Mansi is Consultant Medical Oncologist and Honorary Senior Lecturer at St George's Hospital Medical School, Regional Speciality Advisor for Medical Oncology for South West London and an executive member of the Association of Cancer Physicians.

• List of contributors; 1. History of breast cancer therapy Zenon Rayter; 2. Chemoprevention of breast cancer Tamas Hickish; 3. Familial breast cancer H. Gogas and V. Murday; 4. Hormone replacement therapy and breast cancer J. Marsden and N. P. M. Sacks; 5. Screening for breast cancer Rosalind Given-Wilson; 6. The management of in situ breast cancer Zenon Rayter; 7. Adjuvant systematic therapy T. R. J. Evans; 8. Adjuvant radiotherapy in the management of breast cancer Gillian Ross, David Landau and Andrew Tutt; 9a. Cell kinetic parameters and response to therapy R. S. Camplejohn; 9b. Predictors of response and resistance to medical therapy: endocrine therapy Zenon Rayter; 9c. Predictors of response and resistance to medical therapy: chemotherapy Stephen R. D. Johnson; 10. Primary medical therapy in breast cancer Janine L. Mansi; 11. Medical therapy of advanced disease Alison Jones and Karen McAdam; 12a. High dose chemotherapy in breast cancer John Crown and R. C. F. Leonard; 12b. New immunological approaches to treatment for breast cancer A. G. Dalgleish; 13. The place of bisphosphonates in the management of breast cancer A. H. G. Paterson; 14. Palliative care in breast cancer Janet Hardy; Index.

Review of the hardback: 'The text is thorough, concise, and comprehensive to an extent which is consonant with its size. Factual information is pertinent, up-to-date, and presented with clarity and lack of bias. Controversial issues are discussed in a stimulating and non-dogmatic way with some insightful comments.' The Lancet